4.6 Article

Relaxin-2, pathophysiological insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, Research & Experimental

Relaxin and the Cardiovascular System: from Basic Science to Clinical Practice

Rafael Clara Martins et al.

CURRENT MOLECULAR MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

Julio A. Chirinos et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cell Biology

Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials

Thomas Bernd Dschietzig

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload

Mariana Pintalhao et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Article Cardiac & Cardiovascular Systems

The relationship of circulating relaxin-2 concentrations with short-term prognosis in patients with acute heart failure: the RELAHF study

Pablo Herrero-Puente et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Review Cardiac & Cardiovascular Systems

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Piotr Ponikowski et al.

EUROPEAN HEART JOURNAL (2016)

Review Cardiac & Cardiovascular Systems

Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review

Evelien E. S. van Riet et al.

EUROPEAN JOURNAL OF HEART FAILURE (2016)

Review Cardiac & Cardiovascular Systems

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

Barry A. Borlaug et al.

EUROPEAN HEART JOURNAL (2011)